A reduction in fecal elastase-1 levels below this threshold may serve as a valuable clinical predictor of the development of chronic pancreatitis with exocrine pancreatic insufficiency in patients with osteoarthritis, supported by high sensitivity and specificity that confer strong reliability to the findings. This evidence concerns the gene CELA3B and exocrine pancreatic insufficiency.